Explore the Category
Medical aid scheme premiums rise by nearly twice the rate of inflation. One of the significant cost drivers is the price of imported technology.
The Board of Healthcare Funders comments on the proposed drug pricing regulations in this second of a two part series of articles.
This is the first in a two part series.
The strongest deterrent against FSP compliance missteps is or should be: